Home / Inspections / 741759

FDA Inspection 741759 — Oklahoma Blood Institute

Oklahoma Blood Institute — FEI 1626009

The FDA completed an inspection of Oklahoma Blood Institute on August 26, 2011 in Oklahoma City, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 26, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Oklahoma City, OK (United States)

Facility

Other inspections at this facility

  • 1231637 (NAI Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1093994 (VAI Fri Jun 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1023507 (NAI Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945662 (VAI Thu Aug 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 876145 (NAI Wed May 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources